Reference
  1. WHO. Promoting rational use of medicines: core components. September, 2002.http://archives.who.int/tbs/rational/h3011e.pdf. Accesses September 6, 2020
  2. Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995-2015). BMC public health . Aug 22 2016;16:724. doi:10.1186/s12889-016-3428-8
  3. Witter S, Jones A, Ensor T. How to (or not to) … measure performance against the Abuja target for public health expenditure.Health policy and planning . 2013;29(4):450-455. doi:10.1093/heapol/czt031 %J Health Policy and Planning
  4. WH Organization. WHO Methodology for Point Prevalence Survey on Antibiotic Use in Hospitals, version 1.1. 2018.https://apps.who.int/iris/bitstream/handle/10665/280063/WHO-EMP-IAU-2018.01-eng.pdf?ua=1. Accessed March 15, 2020.
  5. Tonkin-Crine S, Knox K. Changing the antibiotic prescribing behaviour of clinicians in primary care. CMAJ : Canadian Medical Association journal = journal de l’Association medicale canadienne. Feb 2 2016;188(2):94-5. doi:10.1503/cmaj.151103
  6. WH Organization. Drug and therapeutics committees: a practical guide. 2003.https://apps.who.int/iris/bitstream/handle/10665/68553/WHO_EDM_PAR_2004.1.pdf. Accessed January 25 2020.
  7. Health MSf, Organization WH. Drug and Therapeutics Committee Training Course. Submitted to the US Agency for International Development by the Rational Pharmaceutical Management Plus Program. Management Sciences for Health Arlington, VA; 2007.https://www.who.int/medicines/technical_briefing/tbs/Participant-s-Guide-All-Sessions.pdf. Accessed September 6, 2020.
  8. Weekes LM, Brooks C. Drug and Therapeutics Committees in Australia: expected and actual performance. British journal of clinical pharmacology . Nov 1996;42(5):551-7. doi:10.1111/j.1365-2125.1996.tb00048.x
  9. Matlala M, Gous AG, Godman B, Meyer JC. Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications. Expert review of clinical pharmacology . Nov 2017;10(11):1273-1280. doi:10.1080/17512433.2017.1364625
  10. Fadare JO, Ogunleye O, Obiako R, et al. Drug and therapeutics committees in Nigeria: evaluation of scope and functionality.Expert review of clinical pharmacology . Dec 2018;11(12):1255-1262. doi:10.1080/17512433.2018.1549488
  11. Cole CP, James PB, Kargbo AT. An evaluation of the prescribing patterns for under-five patients at a Tertiary Paediatric Hospital in Sierra Leone. Journal of basic and clinical pharmacy . Sep 2015;6(4):109-14. doi:10.4103/0976-0105.168051
  12. Kabba JA, Tadesse N, James PB, et al. Knowledge, attitude and antibiotic prescribing patterns of medical doctors providing free healthcare in the outpatient departments of public hospitals in Sierra Leone: a national cross-sectional study. 2020;
  13. Lakoh S, Adekanmbi O, Jiba DF, et al. Antibiotic use among hospitalized adult patients in a setting with limited laboratory infrastructure in Freetown Sierra Leone, 2017–2018.International Journal of Infectious Diseases . 2020/01/01/ 2020;90:71-76. doi:https://doi.org/10.1016/j.ijid.2019.10.022
  14. Leski TA, Taitt CR, Bangura U, et al. High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone. journal article. April 18 2016;16(1):167. doi:10.1186/s12879-016-1495-1
  15. Leski TA, Bangura U, Jimmy DH, et al. Multidrug-resistant tet(X)-containing hospital isolates in Sierra Leone.International journal of antimicrobial agents . 2013/07/01/ 2013;42(1):83-86. doi:https://doi.org/10.1016/j.ijantimicag.2013.04.014
  16. Witter S, Namakula J, Wurie H, et al. The gendered health workforce: mixed methods analysis from four fragile and post-conflict contexts.Health policy and planning . 2017;32(suppl_5):v52-v62. doi:10.1093/heapol/czx102 %J Health Policy and Planning
  17. Hamilton D, Bugg I. Improving antimicrobial stewardship in the outpatient department of a district general hospital in Sierra Leone.BMJ Open Qual . 2018;7(4):e000495-e000495. doi:10.1136/bmjoq-2018-000495
  18. Promoting Safe and Appropriate Medicine Use in Sierra Leone | Management Sciences for Health. 2020.https://www.msh.org/blog/2017/11/15/promoting-safe-and-appropriate-medicine-use-in-sierra-leone. Accessed September 6, 2020
  19. Strengthening the Pharmaceutical System in Sierra Leone after Ebola | SIAPS Program..http://siapsprogram.org/publication/strengthening-the-pharmaceutical-system-in-sierra-leone-after-ebola. Accessed January 5, 2020.
  20. Sanitation SLMoHa. Sierra Leone Basic Package of Essential Health Services 2015-2020. 2015.https://mohs2017.files.wordpress.com/2017/06/gosl_2015_basic-package-of-essential-health-services-2015-2020.pdf. Accessed September 6, 2020.
  21. Borycki EJIPiHI. Developing a Medical Records System at the Ola During Children’s Hospital, Freetown, Sierra Leone. 2011;164:174.
  22. Sawatsky AP, Ratelle JT, Beckman TJ. Qualitative Research Methods in Medical Education. Anesthesiology . Jul 2019;131(1):14-22. doi:10.1097/aln.0000000000002728
  23. Guidelines for Implementation of Pharmaceutical and Therapeutics Committee in Gauteng Province 2013.http://siapsprogram.org/wp-content/uploads/2014/01/13-191-PTC-Guidelines-Gauteng-SA-FINAL.pdf. Accessed September 6, 2020.
  24. Duran-Garcia E, Santos-Ramos B, Puigventos-Latorre F, Ortega A. Literature review on the Structure and operation of Pharmacy and Therapeutics Committees. International journal of clinical pharmacy . Jun 2011;33(3):475-83. doi:10.1007/s11096-011-9501-6
  25. Giordano V, Koch H, Godoy-Santos A, Dias Belangero W, Esteves Santos Pires R, Labronici P. WhatsApp Messenger as an Adjunctive Tool for Telemedicine: An Overview. Interactive journal of medical research . Jul 21 2017;6(2):e11. doi:10.2196/ijmr.6214
  26. De Benedictis A, Lettieri E, Masella C, et al. WhatsApp in hospital? An empirical investigation of individual and organizational determinants to use. PloS one . 2019;14(1):e0209873. doi:10.1371/journal.pone.0209873
  27. Thomas DR. A General Inductive Approach for Analyzing Qualitative Evaluation Data. 2006;27(2):237-246. doi:10.1177/1098214005283748
  28. Lima-Dellamora Eda C, Caetano R, Gustafsson LL, Godman BB, Patterson K, Osorio-de-Castro CG. An analytical framework for assessing drug and therapeutics committee structure and work processes in tertiary Brazilian hospitals. Basic & clinical pharmacology & toxicology . Sep 2014;115(3):268-76. doi:10.1111/bcpt.12215
  29. Alefan Q, Alshareef S, Al-Shatnawi S. Drug and therapeutics committees in Jordanian hospitals: a nationwide survey of organization, activities, and drug selection procedures. Pharmacy practice . Oct-Dec 2019;17(4):1590. doi:10.18549/PharmPract.2019.4.1590
  30. Plet HT, Hallas J, Nielsen GS, Kjeldsen LJ. Drug and therapeutics committees in Danish hospitals: a survey of organization, activities and drug selection procedures. Basic & clinical pharmacology & toxicology . Apr 2013;112(4):264-9. doi:10.1111/bcpt.12028
  31. Mannebach MA, Ascione FJ, Gaither CA, Bagozzi RP, Cohen IA, Ryan ML. Activities, functions, and Structure of pharmacy and therapeutics committees in large teaching hospitals. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists . Apr 1 1999;56(7):622-8. doi:10.1093/ajhp/56.7.622
  32. Puigventós F, Santos-Ramos B, Ortega A, Durán-García E. Structure and procedures of the pharmacy and therapeutic committees in Spanish hospitals. Pharmacy world & science : PWS . Dec 2010;32(6):767-75. doi:10.1007/s11096-010-9435-4
  33. Hoffmann M. The right drug, but from whose perspective? A framework for analyzing the Structure and activities of drug and therapeutics committees. European journal of clinical pharmacology . May 2013;69 Suppl 1:79-87. doi:10.1007/s00228-013-1491-y
  34. Weekes LM, Brooks C, Day RO. Indicators for Drug and Therapeutics Committees. 1998;45(4):393-398. doi:10.1046/j.1365-2125.1998.t01-1-00699.x
  35. Penm J, Chaar B, Dechun J, Moles R. Formulary systems and pharmacy and therapeutics committees in the Western Pacific Region: exploring two Basel Statements. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists . Jun 1 2013;70(11):967-79. doi:10.2146/ajhp120396
  36. Hoffmann M. The right drug, but from whose perspective? A framework for analyzing the Structure and activities of drug and therapeutics committees. European journal of clinical pharmacology . May 2013;69 Suppl 1(Suppl 1):79-87. doi:10.1007/s00228-013-1491-y
  37. Mashaba TP, Matlala M, Godman B, Meyer JC. Implementation and monitoring of decisions by pharmacy and therapeutics committees in South African public sector hospitals. Expert review of clinical pharmacology . Feb 2019;12(2):159-168. doi:10.1080/17512433.2018.1545572
  38. Sanitation GoSLMoHa. Annual Health Sector Performance Report 2016 . 2016.http://www.afro.who.int/sites/default/files/2017-08/Sierra%20Leone%20Health%20Sector%20%20Performance%20Report%202016.pdf
  39. Bertone MP, Lagarde M. Sources, determinants and utilization of health workers’ revenues: evidence from Sierra Leone. Health policy and planning . 2016;31(8):1010-1019. doi:10.1093/heapol/czw031 %J Health Policy and Planning
  40. Anagnostis E. Writing meeting minutes for a pharmacy and therapeutics committee and its subcommittees. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists . Jan 15 2015;72(2):95-6, 98-9. doi:10.2146/ajhp130639
  41. Abiri OT, Johnson WCN. Pharmacovigilance systems in resource-limited settings: an evaluative case study of Sierra Leone. Journal of pharmaceutical policy and practice . 2019/06/11 2019;12(1):13. doi:10.1186/s40545-019-0173-2
  42. Fijn R, Brouwers JR, Knaap RJ, De Jong-Van Den Berg LT. Drug and Therapeutics (D & T) committees in Dutch hospitals: a nationwide survey of Structure, activities, and drug selection procedures.British journal of clinical pharmacology . Aug 1999;48(2):239-46. doi:10.1046/j.1365-2125.1999.00001.x
  43. Schiff GD, Tripathi JB, Galanter W, et al. Drug formulary decision-making: Ethnographic study of 3 pharmacy and therapeutics committees. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists . Apr 8 2019;76(8):537-542. doi:10.1093/ajhp/zxz022
  44. Leonard MC, Thyagarajan R, Wilson AJ, Sekeres MA. Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists . Apr 1 2018;75(7):451-455. doi:10.2146/ajhp170531
  45. Mikkelsen CM, Andersen SE. A Regional Drug and Therapeutics Committee-led Intervention to Reduce the Hospital Costs of Expensive HIV Drugs. Basic & clinical pharmacology & toxicology . Sep 2016;119(3):278-83. doi:10.1111/bcpt.12585
  46. Perrone J, Nelson LS. Pharmacy and therapeutics committees: leadership opportunities in medication safety for medical toxicologists.Journal of medical toxicology : official journal of the American College of Medical Toxicology . Jun 2011;7(2):99-102. doi:10.1007/s13181-011-0147-5.
  47. Shah N. Managing potential conflicts of interest in state Medicaid pharmacy and therapeutics committees: seeking harmony. JAMA Intern Med . Mar 11 2013;173(5):344. doi:10.1001/jamainternmed.2013.4184.
Table 1 : Membership of drug and therapeutics committee